Exercise of Share Options & Total Voting Rights

IDOX PLC
14 July 2023
 

Idox plc

('Idox' or the 'Group' or the 'Company')

Exercise of Share Options &

Total Voting Rights

 

Idox plc (AIM: IDOX) a leading supplier of specialist information management software and solutions to the public and asset-intensive sectors, announces that it has issued 110,000 new ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to an exercise of options by an employee under its Idox plc Long Term Incentive Plans.

An application has been made for the 110,000 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 17 July 2023.

The Company holds no ordinary shares in treasury. The total number of ordinary shares in issue following Admission will be 454,984,055. Therefore, the total number of ordinary shares with voting rights in the Company will be 454,984,055.

The above figure of 454,984,055 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Enquiries:

Idox plc

+44 (0) 870 333 7101

Chris Stone, Non-Executive Chairman


David Meaden, Chief Executive


Anoop Kang, Chief Financial Officer


 


Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900



Paul Gillam

Michael Burke

James Smith




 


MHP Communications

+44 (0) 203 128 8276

Reg Hoare  

Ollie Hoare
Matthew Taylor

 idox@mhpgroup.com





 



 

About Idox plc For more information see www.idoxplc.com @Idoxgroup

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

IDOX (IDOX)
UK 100

Latest directors dealings